Total Payments
$5,009
2024 Payments
$2,159
Companies
49
Transactions
239
Medicare Patients
2,607
Medicare Billing
$511,531
Payment Breakdown by Category
Food & Beverage$4,934 (98.5%)
Education$74.99 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,934 | 238 | 98.5% |
| Education | $74.99 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $491.58 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $435.42 | 14 | $0 (2024) |
| Daiichi Sankyo Inc. | $400.06 | 19 | $0 (2024) |
| PFIZER INC. | $341.74 | 18 | $0 (2024) |
| Seagen Inc. | $250.20 | 12 | $0 (2023) |
| SOBI, INC | $238.22 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $168.76 | 8 | $0 (2024) |
| GENZYME CORPORATION | $159.97 | 8 | $0 (2023) |
| Amgen Inc. | $147.96 | 7 | $0 (2023) |
| Lilly USA, LLC | $147.84 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,159 | 102 | Daiichi Sankyo Inc. ($286.95) |
| 2023 | $1,461 | 64 | Seagen Inc. ($129.90) |
| 2022 | $588.09 | 32 | Amgen Inc. ($105.11) |
| 2021 | $801.01 | 41 | Janssen Biotech, Inc. ($144.56) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.58 | General |
| 12/18/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 12/04/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/07/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Oncology | ||||||
| 10/02/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Genetically Defined Disease | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 09/16/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Oncology | ||||||
| 09/12/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug), Odomzo | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Oncology | ||||||
| 08/30/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Genetically Defined Disease | ||||||
| 08/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $14.12 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.67 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 573 | 1,630 | $616,781 | $128,626 |
| 2022 | 4 | 611 | 1,546 | $535,917 | $114,281 |
| 2021 | 5 | 685 | 2,103 | $564,820 | $159,862 |
| 2020 | 7 | 738 | 1,897 | $359,832 | $108,762 |
Total Patients
2,607
Total Services
7,176
Medicare Billing
$511,531
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 925 | $377,400 | $78,759 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 84 | 189 | $107,541 | $23,357 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 374 | $107,712 | $22,259 | 20.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 101 | $17,978 | $3,547 | 19.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 41 | $6,150 | $704.64 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 267 | 676 | $275,808 | $58,733 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 268 | 676 | $194,688 | $40,962 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 79 | $44,951 | $10,264 | 22.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 115 | $20,470 | $4,322 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 283 | 958 | $308,320 | $86,227 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 288 | 818 | $175,876 | $51,008 | 29.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 75 | 133 | $58,652 | $16,935 | 28.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 24 | 114 | $17,328 | $4,513 | 26.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 15 | 80 | $4,644 | $1,179 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 218 | 642 | $163,068 | $48,302 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 344 | 895 | $152,150 | $45,902 | 30.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 52 | 68 | $23,256 | $7,052 | 30.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 53 | 124 | $12,648 | $3,716 | 29.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 29 | 126 | $6,300 | $2,151 | 34.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 29 | 29 | $1,305 | $937.00 | 71.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,105 | $701.47 | 63.5% |
About Alan Thomas, PAC
Alan Thomas, PAC is a Physician Assistant healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821142647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alan Thomas, PAC has received a total of $5,009 in payments from pharmaceutical and medical device companies, with $2,159 received in 2024. These payments were reported across 239 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($4,934).
As a Medicare-enrolled provider, Thomas has provided services to 2,607 Medicare beneficiaries, totaling 7,176 services with total Medicare billing of $511,531. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Bakersfield, CA
- Active Since 01/22/2007
- Last Updated 12/07/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821142647
Products in Payments
- ZEJULA (Drug) $265.55
- Enhertu (Drug) $178.03
- JEMPERLI (Biological) $169.87
- TUKYSA (Drug) $168.65
- IBRANCE (Drug) $164.98
- IMBRUVICA (Drug) $163.34
- Orserdu (Drug) $129.80
- REBLOZYL (Biological) $127.39
- VERZENIO (Drug) $126.95
- Doptelet (Drug) $126.70
- XPOVIO (Drug) $122.43
- INJECTAFER (Drug) $121.03
- DARZALEX (Biological) $112.04
- SARCLISA (Biological) $111.31
- CARVYKTI (Drug) $111.27
- CABOMETYX (Drug) $110.70
- LIBTAYO (Biological) $101.70
- DOPTELET (Drug) $101.45
- AYVAKIT (Drug) $97.17
- INLYTA (Drug) $85.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Bakersfield
Mrs. Anita Garrett, P.a.-C, P.A.-C
Physician Assistant — Payments: $32,921
Physician Assistant $32,921
Mr. Melchor Jacob, Np/Pa, NP/PA
Physician Assistant — Payments: $17,690
Physician Assistant $17,690
Mr. Gregory Baker, P.a.-C, P.A.-C
Physician Assistant — Payments: $15,598
Physician Assistant $15,598
Mr. Rodney Beaty, Pa-C, PA-C
Physician Assistant — Payments: $13,616
Physician Assistant $13,616
Iain Gallego, Fnp, FNP
Physician Assistant — Payments: $13,491
Physician Assistant $13,491
Carlos Alvarez, Pa, PA
Physician Assistant — Payments: $10,031
Physician Assistant $10,031